2024
Residual Ultrasound-Enhancing Agents Mimicking Portal Venous Gas
Bitar R, Langdon J, Kaur M, Crandall I, McNamara R, Revzin M. Residual Ultrasound-Enhancing Agents Mimicking Portal Venous Gas. Ultrasound Quarterly 2024, 40: e00694. PMID: 39466239, DOI: 10.1097/ruq.0000000000000694.Peer-Reviewed Original ResearchConceptsUltrasound enhancing agentsPortal venous gasBowel ischemiaAbdominal ultrasoundVenous gasEchogenic fociContrast-enhanced echocardiographyEvaluation of cardiac functionPortal venous systemSeries of casesSonographic detectionCardiac functionDifferential diagnosisPortal veinVenous systemObservational studyLiver parenchymaPortal triadsVascular patencyBowelIschemiaEchocardiographyLiverUltrasound
2020
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
Members W, Heidenreich P, Estes N, Fonarow G, Jurgens C, Kittleson M, Marine J, McManus D, McNamara R. 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation Cardiovascular Quality And Outcomes 2020, 14: e000100. PMID: 33284642, DOI: 10.1161/hcq.0000000000000100.Peer-Reviewed Original Research
2019
Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study
Sibomana J, McNamara R, Walker T. Patient, clinician and logistic barriers to blood pressure control among adult hypertensives in rural district hospitals in Rwanda: a cross-sectional study. BMC Cardiovascular Disorders 2019, 19: 231. PMID: 31638907, PMCID: PMC6805529, DOI: 10.1186/s12872-019-1203-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAntihypertensive AgentsBlood PressureClinical CompetenceCross-Sectional StudiesFemaleGuideline AdherenceHospitals, RuralHumansHypertensionMaleMedication AdherenceMiddle AgedPhysician's RolePractice Guidelines as TopicPractice Patterns, Physicians'RwandaTime FactorsTreatment OutcomeYoung AdultConceptsRural district hospitalDistrict hospitalsBlood pressure controlBarriers to effective blood pressure controlRural Rwandan district hospitalsAssociated with poor blood pressure controlRwandan district hospitalsBarriers to blood pressure controlPoor blood pressure controlMethodsThis cross-sectionalCross-sectional studyLogistical factorsMedication side effectsPressure controlAnti-hypertensive medicationsHypertensive patientsSociodemographic factorsBlood pressureBlood pressure dataPrescribed medicationsEffective blood pressure controlJNC 8 recommendationsGoal blood pressurePatient factorsMedical costs
2000
Management of new onset atrial fibrillation.
McNamara R, Bass E, Miller M, Segal J, Goodman S, Kim N, Robinson K, Powe N. Management of new onset atrial fibrillation. Evidence Report Technology Assessment 2000, 1-7. PMID: 11471248, PMCID: PMC4781222.Peer-Reviewed Original ResearchAdultAge DistributionAgedAged, 80 and overAmbulatory CareAnti-Arrhythmia AgentsAnticoagulantsAspirinAtrial FibrillationClinical Trials as TopicComorbidityDecision Support TechniquesEchocardiographyElectric CountershockEvidence-Based MedicineFemaleHumansIncidenceMaleMiddle AgedPrognosisRisk FactorsSex DistributionSurvival RateThromboembolismTreatment OutcomeDistribution, Severity and Risk Factors for Aortic Atherosclerosis in Cerebral Ischemia
Sen S, Wu K, McNamara R, Lima J, Piantadosi S, Oppenheimer S. Distribution, Severity and Risk Factors for Aortic Atherosclerosis in Cerebral Ischemia. Cerebrovascular Diseases 2000, 10: 102-109. PMID: 10686448, DOI: 10.1159/000016038.Peer-Reviewed Original ResearchConceptsRisk factorsAortic atheromaAortic plaquesCarotid stenosisStroke/TIA patientsSymptomatic coronary artery diseaseAortic plaque thicknessThoracic aortic plaqueTransesophageal echocardiography assessmentIndependent risk factorCoronary artery diseaseIschemic heart diseaseExtracranial carotid stenosisTIA patientsAortic atherosclerosisAsymptomatic patientsIschemic strokeArtery diseaseCerebral ischemiaConsecutive patientsEchocardiography assessmentMultivariable analysisProximal aortaCardiac screeningHeart diseaseThe evidence regarding the drugs used for ventricular rate control.
Segal J, McNamara R, Miller M, Kim N, Goodman S, Powe N, Robinson K, Yu D, Bass E. The evidence regarding the drugs used for ventricular rate control. The Journal Of Family Practice 2000, 49: 47-59. PMID: 10678340.Peer-Reviewed Original ResearchConceptsHeart rate controlExercise toleranceAtrial fibrillationHeart rateBetter heart rate controlCochrane Collaboration's CENTRAL databaseCalcium channel blocker verapamilAbstracts of trialsTrial of verapamilImproved exercise toleranceVentricular rate controlTrials of drugsEnglish-language articlesEnglish-language abstractsCentral databaseVentricular rateBlocker verapamilInsufficient evidenceSystematic reviewPlaceboFibrillationTrialsDrugsLanguage publicationsPatients